Patents Assigned to Mie University
  • TAFI inhibitors and their use to treat pulmonary fibrosis
    Publication number: 20060105995
    Abstract: The invention relates to TAFI inhibitors and their use to treat pulmonary fibrosis.
    Type: Application
    Filed: October 3, 2005
    Publication date: May 18, 2006
    Applicants: Schering Aktiengesellschaft, Mie University Graduate School of Medicine
    Inventors: Hajime Fujimoto, Esteban Gabazza, Michael Morser, Mariko Nagashima, Osamu Taguchi
  • Ti-3 protein derived from triatoma infestans exhibiting activity to inhibit platelet aggregation
    Patent number: 6956106
    Abstract: The present invention provides Ti-3 protein, which is a protein obtained from salivary gland of Triatoma infestans, and the present invention provides Ti-3 gene encoding the protein. As the Ti-3 protein exhibits inhibitory activity on platelet aggregation, a medicine comprising the Ti-3 protein as an active ingredient will serve as a platelet aggregation inhibitor possibly effective for prevention and treatment of myocardial infarction, pulmonary infarction and cerebral infarction. Moreover, the Ti-3 protein will also serve as a highly prospective lead compound in the development of novel platelet aggregation inhibitors.
    Type: Grant
    Filed: March 28, 2003
    Date of Patent: October 18, 2005
    Assignee: Mie University
    Inventors: Akihiro Morita, Haruhiko Isawa, Masao Yuda, Yuki Orito, Yasuo Chinzei
  • Ti-3 protein derived from triatoma infestans exhibiting activity to inhibit platelet aggregation
    Publication number: 20040073005
    Abstract: The present invention provides Ti-3 protein, which is a protein obtained from salivary gland of Triatoma infestans, and the present invention provides Ti-3 gene encoding the protein. As the Ti-3 protein exhibits inhibitory activity on platelet aggregation, a medicine comprising the Ti-3 protein as an active ingredient will serve as a platelet aggregation inhibitor possibly effective for prevention and treatment of myocardial infarction, pulmonary infarction and cerebral infarction. Moreover, the Ti-3 protein will also serve as a highly prospective lead compound in the development of novel platelet aggregation inhibitors.
    Type: Application
    Filed: March 28, 2003
    Publication date: April 15, 2004
    Applicant: Mie University
    Inventors: Akihiro Morita, Haruhiko Isawa, Masao Yuda, Yuki Orito, Yasuo Chinzei
  • Ti-4 protein derived from triatoma infestans exhibiting activity to inhibit platelet aggregation
    Publication number: 20040072194
    Abstract: The present invention provides Ti-4 protein, which is a protein obtained from salivary gland of Triatoma infestans, and the present invention provides Ti-4 gene encoding the protein. As the Ti-4 protein exhibits inhibitory activity on platelet aggregation, a medicine comprising the Ti-4 protein as an active ingredient will serve as a platelet aggregation inhibitor possibly effective for prevention and treatment of myocardial infarction, pulmonary infarction and cerebral infarction. Moreover, the Ti-4 protein will also serve as a highly prospective lead compound in the development of novel platelet aggregation inhibitors.
    Type: Application
    Filed: March 28, 2003
    Publication date: April 15, 2004
    Applicant: Mie University
    Inventors: Akihiro Morita, Haruhiko Isawa, Masao Yuda, Yuki Orito, Yasuo Chinzei